Skip to main content
Top
Published in: Lung 1/2008

01-02-2008

The Utility of Spirometry in Diagnosing Pulmonary Restriction

Authors: Saiprakash B. Venkateshiah, Octavian C. Ioachimescu, Kevin McCarthy, James K. Stoller

Published in: Lung | Issue 1/2008

Login to get access

Abstract

The aim of this retrospective study was to determine the utility of the spirometric measurements FVC, FEV1, and FEV1/FVC in diagnosing pulmonary restriction. Spirometry and lung volume measurements performed on the same patient visit were analyzed. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of (1) FVC < lower limit of normal (LLN) (NHANES III reference values) and (2) FVC < LLN and FEV1/FVC ≥ LLN were compared to diagnose restriction based on lung volume measurements. In all, 18,282 pulmonary function tests from 8,315 patients were analyzed. Twenty-six percent of the patients (n = 2,213) had restriction based on lung volume measurements. The sensitivity, specificity, PPV, and NPV of FVC < LLN to diagnose restriction based on lung volume measurement criteria were 88.6%, 56.8%, 39.9%, and 93.9%, respectively. The sensitivity, specificity, PPV, and NPV of FVC < LLN and FEV1/FVC ≥ normal to diagnose restriction based on lung volume criteria were 72.4%, 87.1%, 64.4%, and 90.7%, respectively. Analysis of ROC curves showed that spirometric criteria based on FVC alone performed better (area under the curve = 0.817) than those based on the combined criteria of FVC and FEV1/FVC (area under the curve = 0.584). Consistent with earlier findings, the negative predictive value for a normal FVC (≥ LLN) to exclude pulmonary restriction was high in this series (up to 95.7%). Also, a spirometric diagnosis of “restriction” (FVC < LLN and FEV1/FVC ≥ LLN) had a positive predictive value of 26.3–73.9%. On this basis, normal FVC can be regarded as excluding restriction with high reliability.
Appendix
Available only for authorised users
Literature
2.
go back to reference Aaron SD, Dales RE, Cardinal P (1999) How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 115:869–873PubMedCrossRef Aaron SD, Dales RE, Cardinal P (1999) How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 115:869–873PubMedCrossRef
3.
go back to reference American Thoracic Society (1995) Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 152:1107–1136 American Thoracic Society (1995) Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 152:1107–1136
4.
go back to reference Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179–187PubMed Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159:179–187PubMed
5.
go back to reference Crapo RO, Morris AH, Clayton PD, Nixon CR (1982) Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 18:419–425PubMed Crapo RO, Morris AH, Clayton PD, Nixon CR (1982) Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 18:419–425PubMed
6.
go back to reference Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B (1983) Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 127:725–734PubMed Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B (1983) Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 127:725–734PubMed
7.
go back to reference Enright PL, Kronmal RA, Higgins M, Schenker M, Haponik EF (1993) Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study. Am Rev Respir Dis 147:125–133PubMed Enright PL, Kronmal RA, Higgins M, Schenker M, Haponik EF (1993) Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study. Am Rev Respir Dis 147:125–133PubMed
8.
go back to reference Glady CA, Aaron SD, Lunau M, Clinch J, Dales RE (2003) A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. Chest 123:1939–1946PubMedCrossRef Glady CA, Aaron SD, Lunau M, Clinch J, Dales RE (2003) A spirometry-based algorithm to direct lung function testing in the pulmonary function laboratory. Chest 123:1939–1946PubMedCrossRef
9.
go back to reference Boros PW, Franczuk M, Wesolowski S (2004) Value of spirometry in detecting volume restriction in interstitial lung disease patients. Respiration 71:374–379PubMedCrossRef Boros PW, Franczuk M, Wesolowski S (2004) Value of spirometry in detecting volume restriction in interstitial lung disease patients. Respiration 71:374–379PubMedCrossRef
Metadata
Title
The Utility of Spirometry in Diagnosing Pulmonary Restriction
Authors
Saiprakash B. Venkateshiah
Octavian C. Ioachimescu
Kevin McCarthy
James K. Stoller
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Lung / Issue 1/2008
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-007-9052-8

Other articles of this Issue 1/2008

Lung 1/2008 Go to the issue

Acknowledgments

Reviewers

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.